These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9333169

  • 1. Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection.
    Elliott SL, Pye SJ, Schmidt C, Cross SM, Silins SL, Misko IS.
    J Infect Dis; 1997 Oct; 176(4):1068-72. PubMed ID: 9333169
    [Abstract] [Full Text] [Related]

  • 2. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.
    Silins SL, Cross SM, Elliott SL, Pye SJ, Burrows JM, Moss DJ, Misko IS.
    Int Immunol; 1997 Nov; 9(11):1745-55. PubMed ID: 9418135
    [Abstract] [Full Text] [Related]

  • 3. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.
    Steven NM, Annels NE, Kumar A, Leese AM, Kurilla MG, Rickinson AB.
    J Exp Med; 1997 May 05; 185(9):1605-17. PubMed ID: 9151898
    [Abstract] [Full Text] [Related]

  • 4. Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus.
    Bogedain C, Wolf H, Modrow S, Stuber G, Jilg W.
    J Virol; 1995 Aug 05; 69(8):4872-9. PubMed ID: 7609055
    [Abstract] [Full Text] [Related]

  • 5. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.
    Burrows SR, Khanna R, Burrows JM, Moss DJ.
    J Exp Med; 1994 Apr 01; 179(4):1155-61. PubMed ID: 7511682
    [Abstract] [Full Text] [Related]

  • 6. Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers.
    Benninger-Döring G, Pepperl S, Deml L, Modrow S, Wolf H, Jilg W.
    Virology; 1999 Nov 25; 264(2):289-97. PubMed ID: 10562493
    [Abstract] [Full Text] [Related]

  • 7. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC, Mowat AG, Fazou C, Rostron T, Roskell H, Dunbar PR, Tournay C, Romagné F, Peyrat MA, Houssaint E, Bonneville M, Rickinson AB, McMichael AJ, Callan MF.
    Arthritis Res; 2000 Nov 25; 2(2):154-64. PubMed ID: 11062606
    [Abstract] [Full Text] [Related]

  • 8. Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies.
    Schmidt C, Burrows SR, Sculley TB, Moss DJ, Misko IS.
    Proc Natl Acad Sci U S A; 1991 Nov 01; 88(21):9478-82. PubMed ID: 1719531
    [Abstract] [Full Text] [Related]

  • 9. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ.
    J Exp Med; 1995 Jun 01; 181(6):2221-8. PubMed ID: 7539044
    [Abstract] [Full Text] [Related]

  • 10. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR, Silins SL, Khanna R, Burrows JM, Rischmueller M, McCluskey J, Moss DJ.
    Eur J Immunol; 1997 Jul 01; 27(7):1726-36. PubMed ID: 9247584
    [Abstract] [Full Text] [Related]

  • 11. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
    Burrows SR, Silins SL, Moss DJ, Khanna R, Misko IS, Argaet VP.
    J Exp Med; 1995 Dec 01; 182(6):1703-15. PubMed ID: 7500015
    [Abstract] [Full Text] [Related]

  • 12. Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease.
    Misko IS, Cross SM, Khanna R, Elliott SL, Schmidt C, Pye SJ, Silins SL.
    Proc Natl Acad Sci U S A; 1999 Mar 02; 96(5):2279-84. PubMed ID: 10051632
    [Abstract] [Full Text] [Related]

  • 13. Accessing Epstein-Barr virus-specific T-cell memory with peptide-loaded dendritic cells.
    Redchenko IV, Rickinson AB.
    J Virol; 1999 Jan 02; 73(1):334-42. PubMed ID: 9847337
    [Abstract] [Full Text] [Related]

  • 14. Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen.
    Misko IS, Schmidt C, Honeyman M, Soszynski TD, Sculley TB, Burrows SR, Moss DJ, Burman K.
    Clin Exp Immunol; 1992 Jan 02; 87(1):65-70. PubMed ID: 1370774
    [Abstract] [Full Text] [Related]

  • 15. A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection.
    Silins SL, Cross SM, Krauer KG, Moss DJ, Schmidt CW, Misko IS.
    J Clin Invest; 1998 Oct 15; 102(8):1551-8. PubMed ID: 9788968
    [Abstract] [Full Text] [Related]

  • 16. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein.
    Turcanová V, Höllsberg P.
    J Med Virol; 2004 Apr 15; 72(4):635-45. PubMed ID: 14981767
    [Abstract] [Full Text] [Related]

  • 17. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
    Khanna R, Burrows SR, Steigerwald-Mullen PM, Thomson SA, Kurilla MG, Moss DJ.
    Virology; 1995 Dec 20; 214(2):633-7. PubMed ID: 8553567
    [Abstract] [Full Text] [Related]

  • 18. A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro.
    Morgan SM, Wilkinson GW, Floettmann E, Blake N, Rickinson AB.
    J Virol; 1996 Apr 20; 70(4):2394-402. PubMed ID: 8642667
    [Abstract] [Full Text] [Related]

  • 19. Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes.
    Pepperl S, Benninger-Döring G, Modrow S, Wolf H, Jilg W.
    J Virol; 1998 Nov 20; 72(11):8644-9. PubMed ID: 9765404
    [Abstract] [Full Text] [Related]

  • 20. Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis.
    Silins SL, Cross SM, Elliott SL, Pye SJ, Burrows SR, Burrows JM, Moss DJ, Argaet VP, Misko IS.
    J Exp Med; 1996 Nov 01; 184(5):1815-24. PubMed ID: 8920869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.